16729-306 : Azacitidine 100 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution


NDC16729-306
Labeler: Accord Healthcare Inc.
Product Type: Human Prescription Drug
Drug Name:  Azacitidine
Dosage Form: Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution
Application #: ANDA207475
Rev. Date: 


NDC Package Codes:

  • 16729-306-10: 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION IN 1 CARTON (16729‑306‑10)

Active Ingredients:

  • Azacitidine

Dosage Strength:

  • 100 mg

Pharmaceutical Classes:

  • Nucleic Acid Synthesis Inhibitors [MoA]
  • Nucleoside Metabolic Inhibitor [EPC]

Related Products:

Based on records with the same trade name.
  • 0591-2897 Azacitidine 100 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Actavis Pharma, Inc.
  • 0781-3253 Azacitidine 100 mg/1 Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Sandoz Inc
  • 0781-9253 Azacitidine 100 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Sandoz Inc
  • 13925-523 Azacitidine 100 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Seton Pharmaceuticals
  • 16714-777 Azacitidine 100 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Northstar Rxllc
  • 16714-927 Azacitidine 100 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Northstar Rxllc
  • 43598-305 Azacitidine 100 mg/1 Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Dr. Reddy's Laboratories Inc.
  • 43598-465 Azacitidine 100 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Dr. Reddy's Laboratories Inc.
  • 43817-906 Azacitidine 100 mg/50ml Subcutaneous Injection, Powder, Lyophilized, for Solution by Panacea Biotec Ltd.
  • 51991-797 Azacitidine 100 mg/50ml Subcutaneous Injection, Powder, Lyophilized, for Solution by Breckenridge Pharmaceutical, Inc.
  • 63323-771 Azacitidine 100 mg/30ml Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Fresenius Kabi USA, LLC
  • 63759-0003 Azacitidine 100 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Shilpa Medicare Limited
  • 64679-096 Azacitidine 100 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Wockhardt USA LLC.
  • 67457-254 Azacitidine 100 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Mylan Institutional LLC
  • 68001-313 Azacitidine 100 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Bluepoint Laboratories
  • 69097-368 Azacitidine 100 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Cipla USA Inc.
  • 72485-201 Azacitidine 100 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Armas Pharmaceuticals Inc.
  • 72606-558 Azacitidine 100 mg Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution by Celltrion USA, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 16729-306 QR Code

< Prev: 16729-302Next: 16729-310 >




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 23 February 2019.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA